{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:46:54Z","timestamp":1764172014591},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s10096-011-1315-x","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T18:32:54Z","timestamp":1309458774000},"page":"337-347","source":"Crossref","is-referenced-by-count":10,"title":["Use of antifungal agents in pediatric and adult high-risk areas"],"prefix":"10.1007","volume":"31","author":[{"given":"E.","family":"Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Borobia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Barrios-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Carcas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,1]]},"reference":[{"issue":"Suppl. 2","key":"1315_CR1","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1093\/clinids\/17.Supplement_2.S487","volume":"17","author":"SE Vartivarian","year":"1993","unstructured":"Vartivarian SE, Anaissie EJ, Bodey GP (1993) Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin Infect Dis 17(suppl 2):S487\u2013S491","journal-title":"Clin Infect Dis"},{"key":"1315_CR2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546\u20131554","journal-title":"N Engl J Med"},{"key":"1315_CR3","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","volume":"328","author":"PA Pizzo","year":"1993","unstructured":"Pizzo PA (1993) Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323\u20131332","journal-title":"N Engl J Med"},{"key":"1315_CR4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0891-5520(20)30714-5","volume":"9","author":"S Hadley","year":"1995","unstructured":"Hadley S, Karchmer AW (1995) Fungal infections in solid organ transplant recipients. Infect Dis Clin North Am 9:1045\u20131074","journal-title":"Infect Dis Clin North Am"},{"key":"1315_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/bbmt.1999.v5.pm10371357","volume":"5","author":"JR Wingard","year":"1999","unstructured":"Wingard JR (1999) Fungal infections after bone marrow transplant. Biol Blood Marrow Transplant 5:55\u201368","journal-title":"Biol Blood Marrow Transplant"},{"key":"1315_CR6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1365-2141.1999.01229.x","volume":"104","author":"EC Williamson","year":"1999","unstructured":"Williamson EC, Millar MR, Steward CG, Cornish JM, Foot AB, Oakhill A, Pamphilon DH, Reeves B, Caul EO, Warnock DW, Marks DI (1999) Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 104:560\u2013568","journal-title":"Br J Haematol"},{"key":"1315_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","volume":"19","author":"L Saiman","year":"2000","unstructured":"Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, Blumberg HM, Patterson JE, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W (2000) Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 19:319\u2013324","journal-title":"Pediatr Infect Dis J"},{"key":"1315_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","volume":"33","author":"HM Blumberg","year":"2001","unstructured":"Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP; National Epidemiology of Mycoses Survey (NEMIS) Study Group (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177\u2013186","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1315_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1309\/AJCPRAAE8LZ7DTNE","volume":"132","author":"S Antinori","year":"2009","unstructured":"Antinori S, Nebuloni M, Magni C, Fasan M, Adorni F, Viola A, Corbellino M, Galli M, Vago G, Parravicini C, Ridolfo AL (2009) Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol 132(2):221\u2013227","journal-title":"Am J Clin Pathol"},{"key":"1315_CR10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/313832","volume":"30","author":"PH Chandrasekar","year":"2000","unstructured":"Chandrasekar PH, Alangaden G, Manavathu E (2000) Aspergillus: an increasing problem in tertiary care hospitals? Clin Infect Dis 30:984\u2013985","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1315_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00019053-200422070-00002","volume":"22","author":"S Dixon","year":"2004","unstructured":"Dixon S, McKeen E, Tabberer M, Paisley S (2004) Economic evaluations of treatments for systemic fungal infections: a systematic review of the literature. Pharmacoeconomics 22(7):421\u2013433","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1315_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-5-1","volume":"5","author":"K With de","year":"2005","unstructured":"de With K, Steib-Bauert M, Knoth H, D\u00f6rje F, Strehl E, Rothe U, Maier L, Kern WV (2005) Hospital use of systemic antifungal drugs. BMC Clin Pharmacol 5(1):1","journal-title":"BMC Clin Pharmacol"},{"issue":"3","key":"1315_CR13","first-page":"127","volume":"22","author":"S Alonso","year":"2009","unstructured":"Alonso S, Arribi A, Vergas J, Mart\u00edn MC, Arce B, Terleira A, Portol\u00e9s A (2009) Estudio piloto de utilizaci\u00f3n de antif\u00fangicos sist\u00e9micos en el Hospital Cl\u00ednico San Carlos. Propuesta de un m\u00e9todo de est\u00fadio. Rev Esp Quimioter 22(3):127\u2013134","journal-title":"Rev Esp Quimioter"},{"key":"1315_CR14","unstructured":"Modified Karch\u2013Lasagna algorithm. Spanish Pharmacovigilance System. In: Aguirre, C. Causalidad en Farmacovigilancia. In: Rodr\u00edguez, J.M., Aguirre, C. (Eds.) Pharmacovigilancia. Bibao: Servicio Editorial de la Universidad del Pa\u00eds Vasco, pp 93\u201398"},{"key":"1315_CR15","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.ejca.2008.07.008","volume":"44","author":"F Meunier","year":"2008","unstructured":"Meunier F, Lukan C (2008) The First European Conference on Infections in Leukaemia\u2014ECIL1: a current perspective. Eur J Cancer 44:2112\u20132117","journal-title":"Eur J Cancer"},{"key":"1315_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik J-A, Wingard JR, Patterson TF; Infectious Diseases Society of America (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327\u2013360","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1315_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3324\/haematol.11665","volume":"94","author":"OA Cornely","year":"2009","unstructured":"Cornely OA, B\u00f6hme A, Buchheidt D, Einsele H, Heinz WJ, Karthaus M, Krause SW, Kr\u00fcger W, Maschmeyer G, Penack O, Ritter J, Ruhnke M, Sandherr M, Sieniawski M, Vehreschild JJ, Wolf HH, Ullmann AJ (2009) Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica 94(1):113\u2013122","journal-title":"Haematologica"},{"issue":"2","key":"1315_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-120-2-199401150-00008","volume":"120","author":"JM Rowe","year":"1994","unstructured":"Rowe JM, Ciobanu N, Ascensao J, Stadtmauer EA, Weiner RS, Schenkein DP, McGlave P, Lazarus HM (1994) Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG). Ann Intern Med 120(2):143\u2013158","journal-title":"Ann Intern Med"},{"key":"1315_CR19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious Diseases Society of America. Clin Infect Dis 48:503\u2013535","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1315_CR20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","volume":"34","author":"C Le\u00f3n","year":"2006","unstructured":"Le\u00f3n C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, \u00c1lvarez-Lerma F, Garnacho-Montero J, Le\u00f3n MA; EPCAN Study Group (2006) A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med 34(3):730\u2013737","journal-title":"Crit Care Med"},{"key":"1315_CR21","unstructured":"Protocolo de diagn\u00f3stico y tratamiento de infecci\u00f3n f\u00fangica invasora en pacientes cr\u00edticos en UCI. Hospital Universitario 12 de Octubre. Madrid. Versi\u00f3n 1. Septiembre 2007"},{"key":"1315_CR22","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","volume":"43","author":"B Almirante","year":"2005","unstructured":"Almirante B, Rodr\u00edguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A; Barcelona Candidemia Project Study Group (2005) Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43:1829\u20131835","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1315_CR23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","volume":"42","author":"RA Hajjeh","year":"2004","unstructured":"Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42(4):1519\u20131527","journal-title":"J Clin Microbiol"},{"key":"1315_CR24","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"O Gudlaugsson","year":"2003","unstructured":"Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172\u20131177","journal-title":"Clin Infect Dis"},{"key":"1315_CR25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","volume":"40","author":"DJ Diekema","year":"2002","unstructured":"Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, Pfaller MA (2002) Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 40:1298\u20131302","journal-title":"J Clin Microbiol"},{"key":"1315_CR26","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","volume":"24","author":"D Abi-Said","year":"1997","unstructured":"Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24:1122\u20131128","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1315_CR27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archsurg.1987.01400140029002","volume":"122","author":"GJ Slotman","year":"1987","unstructured":"Slotman GJ, Burchard KW (1987) Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 122(2):147\u2013151","journal-title":"Arch Surg"},{"key":"1315_CR28","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/archinte.1995.00430220087009","volume":"155","author":"MH Nguyen","year":"1995","unstructured":"Nguyen MH, Peacock JE Jr, Tanner DC, Morris AJ, Nguyen ML, Snydman DR, Wagener MM, Yu VL (1995) Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155:2429\u20132435","journal-title":"Arch Intern Med"},{"issue":"3","key":"1315_CR29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s001340050552","volume":"24","author":"JL Vincent","year":"1998","unstructured":"Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nystr\u00f6m PO, Pittet D, Rogers T, Sandven P, Sganga G, Schaller MD, Solomkin J (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24(3):206\u2013216","journal-title":"Intensive Care Med"},{"key":"1315_CR30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1590\/S1135-57272001000400009","volume":"75","author":"C Prieto Yerro","year":"2001","unstructured":"Prieto Yerro C, Laredo Velasco L, Rodr\u00edguez Bernardino \u00c1, Vargas Castrill\u00f3n E, Ambit \u00c1vila MI, Merchante Medina A (2001) Modificaci\u00f3n en el patr\u00f3n de uso de anfotericina B no convencional tras la puesta en marcha de una intervenci\u00f3n formativa en el Hospital Cl\u00ednico San Carlos de Madrid. Rev Esp Salud P\u00fablica 75:353\u2013360","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"1315_CR31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM200201243460414","volume":"346","author":"JH Powers","year":"2002","unstructured":"Powers JH, Dixon CA, Goldberger MJ (2002) Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever. N Engl J Med 346:289\u2013290","journal-title":"N Engl J Med"},{"key":"1315_CR32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/pds.1365","volume":"16","author":"KW Garey","year":"2007","unstructured":"Garey KW, Pai MP, Suda KJ, Turpin RS, Rege MD, Mingo DE, Bearden DT (2007) Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf 16:919\u2013927","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1315_CR33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/513661","volume":"24","author":"MH White","year":"1997","unstructured":"White MH (1997) The contribution of fluconazole to the changing epidemiology of invasive candidal infections. Clin Infect Dis 24:1129\u20131130","journal-title":"Clin Infect Dis"},{"key":"1315_CR34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jinf.2007.07.003","volume":"55","author":"JJ Vehreschild","year":"2007","unstructured":"Vehreschild JJ, B\u00f6hme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA (2007) A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML). J Infect 55:445\u2013449","journal-title":"J Infect"},{"key":"1315_CR35","doi-asserted-by":"crossref","unstructured":"Playford EG, Webster AC, Sorrell TC, Craig JC (2004) Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database Syst Rev (3):CD004291","DOI":"10.1002\/14651858.CD004291.pub2"},{"issue":"5","key":"1315_CR36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00007890-200209150-00017","volume":"74","author":"DJ Winston","year":"2002","unstructured":"Winston DJ, Busuttil RW (2002) Randomized controlled trial of oral itraconazole solution versus intravenous\/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 74(5):688\u2013695","journal-title":"Transplantation"},{"issue":"11","key":"1315_CR37","first-page":"911","volume":"46","author":"CJ Cai","year":"2007","unstructured":"Cai CJ, Yi SH, Guo Y, Li MR, Yi HM, Yang Y, Lu MQ, Chen GH (2007) The impact of itraconazole versus fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation. Zhonghua Nei Ke Za Zhi 46(11):911\u2013913","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"9","key":"1315_CR38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10096-006-0182-3","volume":"25","author":"EG Playford","year":"2006","unstructured":"Playford EG, Webster AC, Sorrell TC, Craig JC (2006) Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis 25(9):549\u2013561","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"1315_CR39","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1016\/j.transproceed.2005.10.043","volume":"37","author":"JF Castroagud\u00edn","year":"2005","unstructured":"Castroagud\u00edn JF, Pont\u00f3n C, Bustamante M, Otero E, Mart\u00ednez J, Tom\u00e9 S, Conde R, Segade FR, Delgado M, Brage A, Galb\u00e1n C, Varo E (2005) Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients. Transplant Proc 37(9):3965\u20133967","journal-title":"Transplant Proc"},{"key":"1315_CR40","doi-asserted-by":"crossref","unstructured":"Clerihew L, McGuire W (2004) Systemic antifungal drugs for invasive fungal infection in preterm infants. Cochrane Database Syst Rev (1):CD003953","DOI":"10.1002\/14651858.CD003953.pub2"},{"key":"1315_CR41","unstructured":"Austin NC, Darlow B (2004) Prophylactic oral antifungal agents to prevent systemic Candida infection in preterm infants. Cochrane Database Syst Rev (1):CD003478"},{"issue":"1","key":"1315_CR42","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1542\/peds.2004-2227","volume":"117","author":"P Manzoni","year":"2006","unstructured":"Manzoni P, Arisio R, Mostert M, Leonessa M, Farina D, Latino MA, Gomirato G (2006) Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Paediatrics 117(1):e22\u2013e32","journal-title":"Paediatrics"},{"issue":"11","key":"1315_CR43","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/AAC.00569-08","volume":"52","author":"KC Wade","year":"2008","unstructured":"Wade KC, Wu D, Kaufman DA, Ward RM, Benjamin DK Jr, Sullivan JE, Ramey N, Jayaraman B, Hoppu K, Adamson PC, Gastonguay MR, Barrett JS; National Institute of Child Health and Development Pediatric Pharmacology Research Unit Network (2008) Population pharmacokinetics of fluconazole in young infants. Antimicrob Agents Chemother 52(11):4043\u20134049","journal-title":"Antimicrob Agents Chemother"},{"key":"1315_CR44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s150100070040","volume":"28","author":"A Juster-Reicher","year":"2000","unstructured":"Juster-Reicher A, Leibovitz E, Linder N, Amitay M, Flidel-Rimon O, Even-Tov S, Mogilner B, Barzilai A (2000) Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight infants. Infection 28:223\u2013226","journal-title":"Infection"},{"issue":"6","key":"1315_CR45","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/j.ijid.2009.02.003","volume":"13","author":"BH Yang","year":"2009","unstructured":"Yang BH, Peng MY, Hou SJ, Sun JR, Lee SY, Lu JJ (2009) Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature. Int J Infect Dis 13(6):e493\u2013e497","journal-title":"Int J Infect Dis"},{"key":"1315_CR46","unstructured":"World Health Organization (WHO) (2003) Introduction to drug utilization research. WHO, Geneva"},{"issue":"3","key":"1315_CR47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/jac\/dkm255","volume":"60","author":"E Meyer","year":"2007","unstructured":"Meyer E, Schwab F, Gastmeier P, Ruden H, Heininger A (2007) Antifungal use in intensive care units. J Antimicrob Chemother 60(3):619\u2013624","journal-title":"J Antimicrob Chemother"},{"key":"1315_CR48","unstructured":"Cars O, Ekdahl K (2002) SWEDRES 2002. A report on Swedish antibiotic utilisation and resistance in human medicine. The Swedish Strategic Programme for the Rational Use of Antimicrobial Agents (STRAMA) and the Swedish Institute for Infectious Disease Control, Stockholm, pp 1\u201336"},{"key":"1315_CR49","first-page":"390","volume":"20","author":"S Grau","year":"1996","unstructured":"Grau S, Torres-Rodr\u00edguez JM, Monterde J (1996) Situaci\u00f3n actual de las infecciones por hongos: \u00bfSon las anfotericinas lip\u00eddicas la panacea? Farm Hosp 20:390\u2013392","journal-title":"Farm Hosp"},{"key":"1315_CR50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/106002809603000318","volume":"30","author":"O Ericsson","year":"1996","unstructured":"Ericsson O, Hallmen AC, Wikstrom I (1996) Amphotericin B is incompatible with lipid emulsions. Ann Pharmacother 30:298","journal-title":"Ann Pharmacother"},{"issue":"9572","key":"1315_CR51","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","volume":"369","author":"ER Kuse","year":"2007","unstructured":"Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA; Micafungin Invasive Candidiasis Working Group (2007) Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 369(9572):1519\u20131527","journal-title":"Lancet"},{"key":"1315_CR52","unstructured":"Rex JH, Lozano-Chiu M, Paetznik V and co-investigaors of the NIAID MSG Candidiasis Subproject (1998) Susceptibility testing of current Candida bloodstream isolates from Mycoses Study Group (MSG) Collaborative Study #34: isolates of C. krusei are often resistant to both fluconazole and amphotericin B [abstract 324]. In: Program and abstract of 36th Annual Meeting of Infectious Diseases Society of America (Denver): 136"},{"key":"1315_CR53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1469-0691.2007.01899.x","volume":"14","author":"European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST)","year":"2008","unstructured":"European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) (2008) EUCAST technical Note on fluconazole. Clin Microbiol Infect 14:193\u2013195","journal-title":"Clin Microbiol Infect"},{"key":"1315_CR54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00001432-200312000-00015","volume":"16","author":"M Nucci","year":"2003","unstructured":"Nucci M (2003) Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 16:607\u2013612","journal-title":"Curr Opin Infect Dis"},{"key":"1315_CR55","unstructured":"Voriconazole Spanish summary of product characteristics (available at: https:\/\/sinaem4.agemed.es\/consaem\/fichasTecnicas.do?metodo=detalleForm&version=new , last accessed September 28, 2010)"},{"key":"1315_CR56","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","volume":"350","author":"FM Marty","year":"2004","unstructured":"Marty FM, Cosimi LA, Baden LR (2004) Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 350:950\u2013952","journal-title":"N Engl J Med"},{"issue":"2","key":"1315_CR57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-2008-1063858","volume":"29","author":"DI Zonios","year":"2008","unstructured":"Zonios DI, Bennett JE (2008) Update on azole antifungals. Semin Respir Crit Care Med 29(2):198\u2013210","journal-title":"Semin Respir Crit Care Med"},{"key":"1315_CR58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/dkh163","volume":"53","author":"PP Cook","year":"2004","unstructured":"Cook PP, Catrou PG, Christie JD, Young PD, Polk RE (2004) Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 53:853\u2013859","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1315-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1315-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1315-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T07:03:31Z","timestamp":1637996611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1315-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1315"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1315-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}